Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 12, Issue 17, Pages 5597
Publisher
MDPI AG
Online
2023-08-28
DOI
10.3390/jcm12175597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- (2023) Mary E. Rinella et al. HEPATOLOGY
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. Annals of Hepatology
- High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold
- (2023) Laurent Castera et al. DIABETES CARE
- Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study
- (2023) Daniel Q. Huang et al. GASTROENTEROLOGY
- Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
- (2023) Ania M. Jastreboff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes
- (2022) Alessandro Mantovani et al. Journal of Clinical Medicine
- Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
- (2022) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Management of Nonalcoholic Fatty Liver Disease in Primary Care and Endocrinology Clinical Settings
- (2022) Kenneth Cusi et al. Endocrine Practice
- Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial
- (2022) Amalia Gastaldelli et al. Lancet Diabetes & Endocrinology
- Prevalence of elevated liver stiffness in patients with type 1 and type 2 diabetes: A systematic review and meta-analysis
- (2022) Stefano Ciardullo et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- (2022) Kiarash Riazi et al. Lancet Gastroenterology & Hepatology
- 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2023
- (2022) Nuha A. ElSayed et al. DIABETES CARE
- Lack of awareness of liver organ damage in patients with type 2 diabetes
- (2021) Stefano Ciardullo et al. ACTA DIABETOLOGICA
- Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
- (2021) Alessandro Mantovani et al. Metabolites
- NAFLD and liver fibrosis are not associated with reduced femoral bone mineral density in the general US population
- (2021) Stefano Ciardullo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 receptor agonists and reduction of liver fat content in NAFLD patients: Just a question of weight loss?
- (2021) Alessandro Mantovani DIGESTIVE AND LIVER DISEASE
- EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis – 2021 update
- (2021) Annalisa Berzigotti et al. JOURNAL OF HEPATOLOGY
- PPAR‐γ‐induced Changes in Visceral Fat and Adiponectin Levels are Associated with Improvement of Steatohepatitis in Patients with NASH
- (2021) Amalia Gastaldelli et al. LIVER INTERNATIONAL
- Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)
- (2021) Giulio Marchesini et al. DIGESTIVE AND LIVER DISEASE
- Efficacy and safety of anti-hyperglycaemic drugs in patients with non-alcoholic fatty liver disease with or without diabetes: An updated systematic review of randomized controlled trials
- (2020) A. Mantovani et al. DIABETES & METABOLISM
- Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis
- (2020) Rod S. Taylor et al. GASTROENTEROLOGY
- Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD
- (2020) S. Ciardullo et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications
- (2020) Stefano Ciardullo et al. BMJ Open Diabetes Research & Care
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals
- (2020) Alessandro Mantovani et al. GUT
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
- (2020) Sven Francque et al. Nature Reviews Gastroenterology & Hepatology
- High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes
- (2020) Stefano Ciardullo et al. DIABETES CARE
- Advanced Liver Fibrosis Is Common in Patients With Type 2 Diabetes Followed in the Outpatient Setting: The Need for Systematic Screening
- (2020) Romina Lomonaco et al. DIABETES CARE
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Diagnostic Accuracy of Non-Invasive Fibrosis Models to Detect Change in Fibrosis Stage
- (2019) M. Shadab Siddiqui et al. Clinical Gastroenterology and Hepatology
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Diagnostic value of MRI-PDFF for hepatic steatosis in patients with non-alcoholic fatty liver disease: a meta-analysis
- (2019) Jiulian Gu et al. EUROPEAN RADIOLOGY
- Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complications
- (2019) A.J. Scheen DIABETES & METABOLISM
- Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease
- (2019) Ankur Srivastava et al. JOURNAL OF HEPATOLOGY
- Noninvasive tests accurately identify advanced fibrosis due to NASH : Baseline data from the STELLAR trials
- (2019) Quentin M. Anstee et al. HEPATOLOGY
- The Global Epidemiology of NAFLD and NASH in Patients with type 2 diabetes: A Systematic Review and Meta-analysis
- (2019) Zobair M. Younossi et al. JOURNAL OF HEPATOLOGY
- Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis
- (2018) Cyrielle Caussy et al. HEPATOLOGY
- Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions
- (2018) Rohit Loomba JOURNAL OF HEPATOLOGY
- Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
- (2018) Vincent Wai-Sun Wong et al. Nature Reviews Gastroenterology & Hepatology
- Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions
- (2018) Paul Kennedy et al. RADIOLOGY
- American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis
- (2017) Joseph K. Lim et al. GASTROENTEROLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Current and future pharmacological therapies for NAFLD/NASH
- (2017) Yoshio Sumida et al. JOURNAL OF GASTROENTEROLOGY
- Treatment of NAFLD with diet, physical activity and exercise
- (2017) Manuel Romero-Gómez et al. JOURNAL OF HEPATOLOGY
- Use of Liver Imaging and Biopsy in Clinical Practice
- (2017) Elliot B. Tapper et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis
- (2017) Giovanni Musso et al. JAMA Internal Medicine
- NAFLD/NASH in patients with type 2 diabetes and related treatment options
- (2017) M. G. Radaelli et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
- (2016) Kento Imajo et al. GASTROENTEROLOGY
- Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy
- (2016) Christophe Cassinotto et al. HEPATOLOGY
- Time for Glucagon like peptide-1 receptor agonists treatment for patients with NAFLD?
- (2016) Amalia Gastaldelli et al. JOURNAL OF HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
- (2015) Raymond Kwok et al. GUT
- High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
- (2015) Paola Portillo-Sanchez et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis
- (2015) JOURNAL OF HEPATOLOGY
- Mortality From Chronic Liver Diseases in Diabetes
- (2014) Giacomo Zoppini et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Magnetic Resonance Elastography of Liver
- (2014) Sudhakar Kundapur Venkatesh et al. Magnetic Resonance Imaging Clinics of North America
- Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis
- (2011) Ruben Hernaez et al. HEPATOLOGY
- Complication Rate of Percutaneous Liver Biopsies Among Persons With Advanced Chronic Liver Disease in the HALT-C Trial
- (2010) Leonard B. Seeff et al. Clinical Gastroenterology and Hepatology
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
- (2009) Anna Kotronen et al. GASTROENTEROLOGY
- Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
- (2009) Vincent Wai-Sun Wong et al. HEPATOLOGY
- Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease
- (2008) Valerio Nobili et al. GASTROENTEROLOGY
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started